Antitrust exemptions that are pertinent to healthcare include:

Question 21 options:

a)

Noerr-Pennington Doctrine

b)

Health Care Quality Improvement Act

c)

Mc Carran-Ferguson Act

d)

Implied Repeal Doctrine

e)

State Action Doctrine

f)

All of the above

g)

None of the above

Which of the following statements is true?:

Question 22 options:

a)

The Rule of Reason Analysis, used in antitrust cases, is detailed examination of issues including the geographical and product markets;

b)

Competitive behaviors that involve group boycotts and tying arrangements are per se violations of antitrust laws;

c)

Antitrust concerns for pharmaceutical manufacturers include such things as price fixing and restraint of trade;

d)

The Herfindahl-Hirschman Index is used in antitrust cases to measure market concentration;

e)

Antitrust safety zones and advisory opinions are used by providers to limit or eliminate antitrust exposure.

f)

All of the above;

g)

None of the above;

Which of the following statements is false:

Question 23 options:

a)

Under the Federal Trade Commission Act, product labeling is a violation;

b)

Under the Sherman Act, with monopolization allegations courts determine the relevant market whether product or geographically;

c)

Under the Sherman Act, competitors sharing information which leads to stabilizing prices constitutes a violation;

d)

Under the Federal Trade Commission Act, failing to reveal material facts about a product is a violation;

e)

Under the Clayton Act, contracts for exclusive dealing are permissible;